'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook (Q26786089)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook
scientific article

    Statements

    0 references
    7 references
    25 April 2019
    18 June 2019
    31 July 2019
    27 November 2019
    13 December 2019
    15 December 2019
    19 December 2019
    'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook (English)
    0 references
    0 references
    0 references
    3 references
    25 April 2019
    18 June 2019
    31 July 2019
    1 reference
    31 July 2019
    1 reference
    27 November 2019
    1 reference
    13 December 2019
    1 reference
    15 December 2019
    1 reference
    19 December 2019
    S Jarius
    0 references
    B Wildemann
    0 references
    17 September 2015
    12
    0 references
    1
    0 references
    168
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit